Govt makes affordable Sitagliptin combinations for diabetics available at Janaushadhi Kendras

Source :: BioSpectrum (India). September 16, 2022
Publication Year :: 2022
Abstract: New variant of diabetes medicines introduced at affordable prices under Pradhan Mantri Bhartiya Janaushadhi Pariyojana The Chief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Ravi Dadhich [...]

Subjects :: Sitagliptin -- Economic aspects
Metformin -- Economic aspects
Type 2 diabetes -- Economic aspects
Diabetics -- Economic aspects
Phosphates -- Economic aspects
Biotechnology industry

Tools